Endoscopy technology company Jiesibaier Medical just completed a few million dollars in Series A financing, this round of financing was led by Bio Venture. At present, Chinese spinal surgery and the spine endoscopy industry are in rapid development. According to incomplete statistics, the annual volume of percutaneous endoscopy in China has grown from less than 10,000 units a few years ago to more than 100,000 units, and is still increasing in double digits every year.
Jiesibaier Medical is one of the few Chinese companies that have some core patients in the field of spinal surgery and spine endoscopy industry. The current team is using the latest new technologies to improve its auxiliary robot and AI. Based on advanced foreign technologies and their own development, Jlecheng Medical believes they can help this industry to improve in China.
About Bio Venture
Bio Venture is a Chinese venture capital firm that offers early and growth-stage investment services.